Peptide receptor radionuclide therapy (PRRT)
Established receptor-targeted radiation for selected neuroendocrine tumors
PRRT attaches a radioactive substance to a molecule that binds to receptors on certain neuroendocrine tumor cells. The treatment travels through the bloodstream and delivers radiation where it binds. Lutetium-177 DOTATATE is an established example for selected somatostatin receptor-positive gastroenteropancreatic…
Read the guide